Delayed diagnosis of critical congenital heart defects: trends and associated factors

Rebecca F Liberman1, Kelly D Getz2, Angela E Lin3

  • 1Massachusetts Department of Public Health, Boston, Massachusetts; rebecca.liberman@state.ma.us.

Pediatrics
|July 30, 2014
PubMed

Insights

Delayed diagnosis of critical congenital heart defects (CCHDs) still affects over 10% of infants. Delivery outside a major hospital and isolated defects are linked to delayed diagnosis, highlighting areas for improved screening.

Area of Science:

  • Pediatric Cardiology
  • Public Health
  • Medical Diagnostics

Background:

  • Critical congenital heart defects (CCHDs) are a significant cause of infant morbidity and mortality.
  • Early diagnosis is crucial for timely intervention and improved outcomes in CCHD cases.
  • Trends in CCHD diagnosis timing and associated factors require ongoing investigation.

Purpose of the Study:

  • To analyze trends in the timing of CCHD diagnosis.
  • To identify factors contributing to delayed diagnosis of CCHDs after hospital discharge.
  • To inform improvements in CCHD screening and diagnostic strategies.

Main Methods:

  • Retrospective cohort study of live births in Massachusetts (2004-2009).
  • Identification of CCHD cases using the Massachusetts Birth Defects Monitoring Program.
  • Analysis of diagnostic timing (prenatal, postnatal before discharge, delayed) and associated factors using prevalence ratios.

Main Results:

  • Among 916 CCHD cases, 13.8% experienced delayed diagnosis.
  • Prenatal diagnosis rates increased from 44.9% to 63.8% (2004-2009), while delayed diagnoses decreased from 17.1% to 10.6%.
  • Delayed diagnosis was associated with delivery outside a tertiary hospital (aPR 3.6) and isolated CCHDs (aPR 1.7).

Conclusions:

  • Despite advances, over 10% of CCHDs are diagnosed after discharge.
  • Delivery location and defect type are key factors in delayed diagnosis.
  • Enhanced prenatal and postnatal screening, including pulse oximetry, is vital for reducing delayed CCHD diagnoses.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
683
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
550
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
786
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
493